Bob Nelsen at #JPM23 (Adrien Villez for Endpoints News)
April 23, 2024 08:00 AM EDTUpdated 10:53 AM
People
Startups
AI

Why VC leg­end Bob Nelsen is mak­ing the biggest ini­tial bet of his 37-year ca­reer on Xaira

Andrew Dunn

Senior Biopharma Correspondent

Ryan Cross

Senior Science Correspondent

In the 37 years since co-found­ing ARCH Ven­ture Part­ners, Bob Nelsen has built a rep­u­ta­tion for plac­ing head-turn­ing bets on ideas that car­ry huge amounts …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Rhythm re­ceives ex­pand­ed ap­proval for ge­net­ic obe­si­ty drug

A service from the Financial Times